Hybio Pharmaceutical Free Cash Flow Generation Index
Hybio Pharmaceutical free cash flow generation index. Hybio Pharmaceutical (300199) has a Free Cash Flow Generation Index of 0.19x as of September 2025. Free cash flow of CN¥22.18 Million represents 0% of operating cash flow (CN¥117.78 Million). Check 300199 financial resilience to evaluate the company's liquid asset resilience ratio.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Hybio Pharmaceutical (2007–2024)
Free cash flow generation index of Hybio Pharmaceutical from 2007 to 2024. Historical FCF Generation Index trend for Hybio Pharmaceutical across 17 annual periods. Explore 300199 capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Hybio Pharmaceutical Free Cash Flow Generation Index by Year (2007–2024)
Hybio Pharmaceutical free cash flow generation index by year from 2007 to 2024. Year-by-year Free Cash Flow Generation Index for Hybio Pharmaceutical. For the full cash flow conversion analysis, see Hybio Pharmaceutical (300199) cash conversion ratio.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.30x | CN¥48.87 Million | CN¥164.71 Million | CN¥115.84 Million | ▲ +102.7% |
| 2022 | -11.01x | CN¥-174.04 Million | CN¥15.81 Million | CN¥189.85 Million | ▼ -3994.5% |
| 2021 | -0.27x | CN¥-42.17 Million | CN¥156.83 Million | CN¥199.00 Million | ▲ +93.4% |
| 2020 | -4.08x | CN¥-195.67 Million | CN¥47.99 Million | CN¥243.66 Million | ▲ +8.4% |
| 2019 | -4.45x | CN¥-465.52 Million | CN¥104.64 Million | CN¥570.15 Million | ▲ +34.4% |
| 2018 | -6.78x | CN¥-318.58 Million | CN¥47.00 Million | CN¥365.58 Million | ▼ -19492.8% |
| 2017 | -0.03x | CN¥-7.39 Million | CN¥213.74 Million | CN¥221.14 Million | ▼ -105.7% |
| 2016 | 0.61x | CN¥180.36 Million | CN¥296.41 Million | CN¥116.05 Million | ▲ +138.4% |
| 2015 | -1.59x | CN¥-220.14 Million | CN¥138.84 Million | CN¥358.98 Million | ▼ -456.4% |
| 2014 | 0.44x | CN¥68.26 Million | CN¥153.43 Million | CN¥85.16 Million | ▲ +145.7% |
| 2013 | -0.97x | CN¥-149.38 Million | CN¥153.48 Million | CN¥302.85 Million | ▲ +36.8% |
| 2012 | -1.54x | CN¥-134.19 Million | CN¥87.19 Million | CN¥221.38 Million | ▼ -1826.5% |
| 2011 | -0.08x | CN¥-5.79 Million | CN¥72.48 Million | CN¥78.27 Million | ▼ -113.7% |
| 2010 | 0.58x | CN¥31.87 Million | CN¥54.69 Million | CN¥22.83 Million | ▼ -11.1% |
| 2009 | 0.66x | CN¥17.10 Million | CN¥26.11 Million | CN¥9.01 Million | ▲ +306.2% |
| 2008 | -0.32x | CN¥-14.53 Million | CN¥45.75 Million | CN¥60.28 Million | ▼ -135.3% |
| 2007 | 0.90x | CN¥44.14 Million | CN¥49.04 Million | CN¥4.90 Million | — |